Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Recombinant proteins
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : GeoVax Labs
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Sino Biological will provide key bioreagents such as recombinant proteins, antibodies and detection kits for use in COVID-19 vaccine development underway at GeoVax.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
April 30, 2020
Lead Product(s) : Recombinant proteins
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : GeoVax Labs
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?